Open
SectorHealthcare
113.8 -0.44
24h
Min
112.78
Max
115.76
Income | -11M -42M |
---|---|
Sales | 2.5M 45M |
P/E Sector Avg | 47.016 50.291 |
EPS | 1.33 |
Profit margin | -93.643 |
Employees | 68 |
EBITDA | -11M -41M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +27.06% upside |
Next Earnings | 5 sie 2025 |
---|
Market Cap | 201M 2.2B |
---|---|
Previous open | 114.24 |
Previous close | 113.8 |
By Acuity
39%
61%
128 / 380 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 147 USD 27.06%
High 157 USD
Low 135 USD
Based on 6 Wall Street analysts offering 12 month price targets forLigand Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$